Inside the Practice: Inside New Drugs for Viral Infections

Michael Samsonov discusses the repositioning of existing drugs for newly emerged viral infections with a focus on olokizumab. We delve into the importance of repositioning existing drugs during the COVID-19 pandemic, the real-world evidence tools his team is utilizing, and future research he is planning on doing in the future to address this opportunity.